Business · 17/12/2020Updated: 10/17/2026 · 1 min read
FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product
Summary
The FDA has awarded a priority review voucher to Eiger BioPharmaceuticals, Inc. for its rare pediatric disease product application, ZOKINVY (lonafarnib), which is manufactured by the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →